3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
6
Solitary Fibrous Tumors
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Recurrent High Grade Meningioma
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Histiocytoma, Malignant Fibrous
1
Hemangioendothelioma
1
Chondrosarcoma, Mesenchymal
1
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Trabectedin
×
1 year
×
Clear all
NCT04008238
2026-03-06
PIPER
Institut Bergonié
Phase NA
Completed
29 enrolled